Antisera to Human Fragment

FDA 510(k) K790711 · Kent Laboratories, Inc.

Substantially Equivalent

510(k) numberK790711

Submission

Device name
Antisera to Human Fragment
Applicant
Kent Laboratories, Inc.
Mchenry, IL, US
Received
April 12, 1979
Decision date
September 4, 1979
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)

Official FDA 510(k) record

Device classification

Product code
DFK – Igg (Fab Fragment Specific), Antigen, Antiserum, Control
Device class
Class I (low risk)
Regulation
21 CFR 866.5520
Specialty
Immunology

Other 510(k)s with product code DFK

510(k)DeviceApplicantDecision
K771243Antisera to Human Fab FragmentDFK · Traditional Kent Laboratories, Inc.08/03/1977SE
K770670Flor. Conjug. Human Fab FragmentDFK · Traditional Kent Laboratories, Inc.04/28/1977SE

More from Kent Laboratories, Inc.

510(k)DeviceDecision
K951966Human Prealbumin Radial Immunodiffusion KitJZJ · Traditional 06/01/1995SE
K951968Human C1Q Radial Immunodiffusion KitDAK · Traditional 05/30/1995SE
K951967Human C1 Inactivator or C-1 Esterase Inhibitor Radial Immunodiffusion KitDBA · Traditional 05/30/1995SE
K950102Human C-5 Radial Immunodiffusion KitDAY · Traditional 04/10/1995SE
K85068372 Determ. Size Radial Immunodiffusion Test ALPHA2DEB · Traditional 11/27/1985SE
K85068272 Determ. Size Radial Immuno. Test Human CeruloplDDB · Traditional 11/25/1985SE
K850691Antiserum to Human Apolipoprotein A-IMSJ · Traditional 11/01/1985SE
K850690Antiserum to Human Apolipoprotein BMSJ · Traditional 11/01/1985SE
K850686Antiserum to Human PrealbuminJZJ · Traditional 11/01/1985SE
K831961Immunodiffusion Test Human AntithrombinJBQ · Traditional 08/11/1983SE

Questions and answers

When was Antisera to Human Fragment cleared by the FDA?

Antisera to Human Fragment (K790711) received a 510(k) decision of Substantially Equivalent on September 4, 1979, 145 days after the submission was received.

What is the product code of K790711?

The FDA product code is DFK – Igg (Fab Fragment Specific), Antigen, Antiserum, Control, a Class I (low risk) device regulated under 21 CFR 866.5520.